| REGISTERED NUMBER: |
| Unaudited Financial Statements for the Year Ended 31 December 2025 |
| for |
| Nekologic Ltd |
| REGISTERED NUMBER: |
| Unaudited Financial Statements for the Year Ended 31 December 2025 |
| for |
| Nekologic Ltd |
| Nekologic Ltd (Registered number: 13068940) |
| Contents of the Financial Statements |
| for the Year Ended 31 December 2025 |
| Page |
| Company Information | 1 |
| Statement of Financial Position | 2 |
| Notes to the Financial Statements | 4 |
| Nekologic Ltd |
| Company Information |
| for the Year Ended 31 December 2025 |
| Director: |
| Registered office: |
| Registered number: |
| Accountants: |
| Chartered Accountants |
| 114-120 Northgate Street |
| Chester |
| CH1 2HT |
| Nekologic Ltd (Registered number: 13068940) |
| Statement of Financial Position |
| 31 December 2025 |
| 31/12/25 | 31/12/24 |
| Notes | £ | £ | £ | £ |
| Fixed assets |
| Tangible assets | 4 |
| Investments | 5 |
| Current assets |
| Debtors | 6 |
| Investments | 7 |
| Cash at bank |
| Creditors |
| Amounts falling due within one year | 8 |
| Net current assets |
| Total assets less current liabilities |
| Provisions for liabilities |
| Net assets |
| Capital and reserves |
| Called up share capital |
| Retained earnings |
| The director acknowledges his responsibilities for: |
| (a) | ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and |
| (b) | preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company. |
| Nekologic Ltd (Registered number: 13068940) |
| Statement of Financial Position - continued |
| 31 December 2025 |
| The financial statements were approved by the director and authorised for issue on |
| Nekologic Ltd (Registered number: 13068940) |
| Notes to the Financial Statements |
| for the Year Ended 31 December 2025 |
| 1. | Statutory information |
| Nekologic Ltd is a |
| 2. | Accounting policies |
| Basis of preparing the financial statements |
| Turnover |
| Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. |
| Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer, usually on despatch of the goods; the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity and the costs incurred or to be incurred in respect of the transactions can be measured reliably. |
| Revenue from the rendering of services is measured by reference to the stage of completion of the service transaction at the end of the reporting period provided that the outcome can be reliably estimated. When the outcome cannot be reliably estimated, revenue is recognised only to the extent that expenses recognised are recoverable. |
| Tangible fixed assets |
| Computer equipment | - |
| Investments in subsidiaries |
| Investments in subsidiary undertakings are recognised at cost. |
| Taxation |
| Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. |
| Current or deferred taxation assets and liabilities are not discounted. |
| Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date. |
| Nekologic Ltd (Registered number: 13068940) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 December 2025 |
| 2. | Accounting policies - continued |
| Deferred tax |
| Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date. |
| Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference. |
| Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. |
| Foreign currencies |
| Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the statement of financial position date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result. |
| Pension costs and other post-retirement benefits |
| The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate. |
| Current asset investments |
| Listed investments are measured at fair value with changes in fair value being recognised in profit or loss. |
| 3. | Employees and directors |
| The average number of employees during the year was |
| 4. | Tangible fixed assets |
| Computer |
| equipment |
| £ |
| Cost |
| At 1 January 2025 |
| and 31 December 2025 |
| Depreciation |
| At 1 January 2025 |
| Charge for year |
| At 31 December 2025 |
| Net book value |
| At 31 December 2025 |
| At 31 December 2024 |
| Nekologic Ltd (Registered number: 13068940) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 December 2025 |
| 5. | Fixed asset investments |
| Shares in |
| group |
| undertakings |
| £ |
| Cost |
| Additions |
| At 31 December 2025 |
| Net book value |
| At 31 December 2025 |
| The company's investments at 31 December 2025 in subsidiary undertakings comprise holdings of 80% of the share capital or capital stock, as appropriate, of the following companies. |
Name |
Address of the registered office |
Country of incorporation |
Nature of business |
| Nekologic LLC | Shinnyodo Habitation 401, 162-6 Jodoji Shinnyocho, Kyoto City |
Japan |
Software development |
| The company’s investment in Nekologic LLC. is direct ownership. |
| 6. | Debtors: amounts falling due within one year |
| 31/12/25 | 31/12/24 |
| £ | £ |
| Other debtors |
| 7. | Current asset investments |
| 31/12/25 | 31/12/24 |
| £ | £ |
| Listed investments | 30,490 | 25,947 |
| 8. | Creditors: amounts falling due within one year |
| 31/12/25 | 31/12/24 |
| £ | £ |
| Taxation and social security |
| Other creditors |
| Nekologic Ltd (Registered number: 13068940) |
| Notes to the Financial Statements - continued |
| for the Year Ended 31 December 2025 |
| 9. | Director's advances, credits and guarantees |
| The following advances and credits to a director subsisted during the years ended 31 December 2025 and 31 December 2024: |
| 31/12/25 | 31/12/24 |
| £ | £ |
| Balance outstanding at start of year |
| Amounts advanced |
| Amounts repaid | ( |
) | ( |
) |
| Amounts written off | - | - |
| Amounts waived | - | - |
| Balance outstanding at end of year |
| Advances to the director are interest-free and repayable on demand. The maximum balance outstanding in the year was £7,274. |